Brain Levels of Prostaglandins, Endocannabinoids, and Related Lipids Are Affected by Mating Strategies

Table 2

Levels of lipid production in olfactory bulbs, hypothalamus, thalamus, and cerebellum across the four treatment groups: home cage control, chamber exposed, standard mated, and paced mated.

	Home cage	Chamber exposed	Standard mated	Paced mated
Olfactory bulbs
AEA	8.2𝐸−11±2.4𝐸−11	6.8𝐸−11±1.0𝐸−11	7.1𝐸−11±1.6𝐸−11	9.8𝐸−11±3.8𝐸−11
NAGly	1.8𝐸−11±5.4𝐸−12	2.3𝐸−11±4.4𝐸−12	1.7𝐸−11±4.9𝐸−12	3.1𝐸−11±2.0𝐸−11
PEA	4.1𝐸−12±1.2𝐸−12	3.9𝐸−12±9.6𝐸−13	3.7𝐸−12±1.3𝐸−12	2.2𝐸−12±3.0𝐸−13
SEA	6.2𝐸−11±1.5𝐸−11	6.4𝐸−11±1.5𝐸−11	6.0𝐸−11±1.8𝐸−11	4.5𝐸−11±6.9𝐸−12
OEA	8.4𝐸−11±1.6𝐸−11	9.3𝐸−11±1.3𝐸−11	8.2𝐸−11±2.1𝐸−11	4.7𝐸−11±4.3𝐸−12
DHEA	4.3𝐸−11±1.5𝐸−11	2.7𝐸−11±3.1𝐸−12	5.6𝐸−11±2.1𝐸−11	3.5𝐸−11±1.4𝐸−11
2-AG	2.6𝐸−9±1.3𝐸−10	2.1𝐸−9±2.9𝐸−10	2.6𝐸−9±3.2𝐸−10	2.6𝐸−9±2.7𝐸−10
PGE2	9.1𝐸−10±1.6𝐸−10	8.1𝐸−10±1.9𝐸−10	6.5𝐸−10±1.8𝐸−10	6.5𝐸−10±9.4𝐸−11
PGF2α	3.0𝐸−10±5.3𝐸−11	2.5𝐸−10±5.5𝐸−11	2.1𝐸−10±5.2𝐸−11	3.2𝐸−10±1.1𝐸−10
Hypothalamus
AEA	1.2𝐸−10±8.0𝐸−11	1.4𝐸−11±1.9𝐸−11	9.8𝐸−11±6.6𝐸−12	1.1𝐸−10±2.3𝐸−11
NAGly	7.1𝐸−12±1.6𝐸−12	1.1𝐸−11±2.2𝐸−12	6.1𝐸−12±1.5𝐸−12	1.0𝐸−11±2.0𝐸−12
PEA	1.4𝐸−10±1.9𝐸−11	1.0𝐸−11±1.3𝐸−12	7.1𝐸−12±5.2𝐸−13	9.0𝐸−12±3.1𝐸−12
SEA	1.8𝐸−10±2.5𝐸−11	1.7𝐸−10±2.3𝐸−11	1.5𝐸−10±1.6𝐸−11	2.1𝐸−10±7.8𝐸−11
OEA	1.6𝐸−11±2.2𝐸−12	2.6𝐸−10±2.7𝐸−11	1.9𝐸−10±2.2𝐸−11	2.5𝐸−10±8.9𝐸−11
DHEA	7.6𝐸−9±1.0𝐸−9	3.0𝐸−11±8.9𝐸−12	2.4𝐸−11±3.0𝐸−12	3.0𝐸−11±10.0𝐸−12
2-AG	7.6𝐸−9±1.0𝐸−9	8.5𝐸−9±3.0𝐸−9	7.4𝐸−9±2.3𝐸−9	7.2𝐸−9±1.6𝐸−9
PGE2	2.4𝐸−10±7.1𝐸−11	4.0𝐸−10±7.5𝐸−11	2.9𝐸−10±5.9𝐸−11	5.0𝐸−10±1.3𝐸−10
PGF2α	1.6𝐸−10±3.0𝐸−11	2.1𝐸−10±2.4𝐸−11	1.7𝐸−10±3.0𝐸−11	2.7𝐸−10±5.5𝐸−11
Thalamus
AEA	3.3𝐸−11±1.5𝐸−12	3.7𝐸−11±6.8𝐸−12	3.7𝐸−11±4.9𝐸−12	2.2𝐸−11±1.7𝐸−12
NAGly	1.6𝐸−11±2.1𝐸−12	2.0𝐸−11±3.6𝐸−12	1.9𝐸−11±2.2𝐸−12	1.2𝐸−11±5.9𝐸−13
PEA	2.4𝐸−11±1.8𝐸−12	3.1𝐸−11±6.2𝐸−12	2.6𝐸−11±3.8𝐸−12	1.8𝐸−11±1.1𝐸−12
SEA	3.5𝐸−10±2.8𝐸−11	4.2𝐸−10±7.0𝐸−11	3.9𝐸−10±3.5𝐸−11	3.5𝐸−10±2.7𝐸−11
OEA	4.9𝐸−10±3.4𝐸−11	6.2𝐸−10±1.1𝐸−10	5.6𝐸−10±6.7𝐸−11	3.8𝐸−10±2.9𝐸−11
DHEA	1.1𝐸−10±5.7𝐸−12	1.4𝐸−10±1.8𝐸−11	1.3𝐸−10±1.3𝐸−11	1.0𝐸−10±6.5𝐸−12
2-AG	1.8𝐸−8±1.4𝐸−9	1.5𝐸−8±10.0𝐸−10	1.8𝐸−8±1.0𝐸−9	1.8𝐸−8±1.2𝐸−9
PGE2	1.8𝐸−10±2.3𝐸−11	1.9𝐸−10±4.6𝐸−11	2.0𝐸−10±5.1𝐸−11	1.9𝐸−10±2.0𝐸−11
PGF2α	2.2𝐸−10±1.9𝐸−11	1.8𝐸−10±2.7𝐸−11	2.0𝐸−10±3.0𝐸−11	1.8𝐸−10±1.5𝐸−11
Cerebellum
AEA	3.4𝐸−12±4.4𝐸−13	5.4𝐸−12±1.1𝐸−12	3.2𝐸−12±2.4𝐸−13	4.0𝐸−12±2.6𝐸−13
NAGly	7.3𝐸−12±3.3𝐸−13	9.3𝐸−12±1.5𝐸−12	7.7𝐸−12±4.7𝐸−13	5.9𝐸−12±4.2𝐸−13
PEA	4.4𝐸−12±2.5𝐸−13	6.6𝐸−12±1.2𝐸−12	4.8𝐸−12±1.7𝐸−13	4.5𝐸−12±5.6𝐸−13
SEA	9.5𝐸−11±5.4𝐸−12	1.4𝐸−10±2.1𝐸−11	1.2𝐸−10±3.5𝐸−12	1.1𝐸−10±1.1𝐸−11
OEA	1.1𝐸−10±3.9𝐸−12	1.6𝐸−10±3.0𝐸−11	1.2𝐸−10±4.9𝐸−12	1.1𝐸−10±9.6𝐸−12
DHEA	2.1𝐸−11±7.0𝐸−13	3.1𝐸−11±4.9𝐸−12	2.3𝐸−11±2.7𝐸−13	2.6𝐸−11±1.9𝐸−12
2-AG	3.2𝐸−9±1.6𝐸−10	3.4𝐸−9±1.7𝐸−10	3.3𝐸−9±1.3𝐸−10	3.9𝐸−9±4.5𝐸−10
PGE2	9.5𝐸−11±1.1𝐸−11	8.4𝐸−11±8.3𝐸−12	1.1𝐸−10±9.2𝐸−12	8.0𝐸−11±1.7𝐸−11
PGF2α	5.3𝐸−11±4.8𝐸−12	5.1𝐸−11±8.3𝐸−12	5.6𝐸−11±3.6𝐸−12	3.7𝐸−11±4.4𝐸−12